Surge in Open Interest Signals Increased Market Activity for Sun Pharmaceutical Industries
Sun Pharmaceutical Industries Ltd has seen a notable rise in open interest, reaching 89,401 contracts, alongside a trading volume of 37,601 contracts. The stock has gained modestly and has shown an upward trend over the past four days, despite a decline in delivery volume compared to its recent average.
Sun Pharmaceutical Industries Ltd (symbol: SUNPHARMA) has experienced a significant increase in open interest today, reflecting heightened activity in its futures market. The latest open interest stands at 89,401 contracts, up from the previous 76,936, marking a change of 12,465 contracts or a 16.2% increase. This surge in open interest coincides with a trading volume of 37,601 contracts, indicating robust market engagement.In terms of price performance, Sun Pharmaceutical has shown a modest gain of 0.22% today, aligning closely with the sector's performance, which recorded a 0.24% increase. The stock has been on an upward trajectory for the past four days, accumulating a total return of 1.21% during this period. However, it has traded within a narrow range of Rs 15.2, suggesting limited volatility.
Despite the positive movement in open interest, the stock's delivery volume has seen a decline of 5.38% compared to its five-day average, indicating a potential decrease in investor participation. The stock remains liquid, with a trading capacity of Rs 7.64 crore based on 2% of the five-day average traded value. Overall, the notable increase in open interest highlights a shift in market dynamics for Sun Pharmaceutical Industries, reflecting ongoing developments in the pharmaceutical and biotechnology sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
